USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA

USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA The present invention relates to the use of agomelatine, or N-[2-(7-methoxy- l-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of periventricular leukomalacia.

Saved in:
Bibliographic Details
Main Authors MOCAER ELISABETH, SPEDDING MICHAEL
Format Patent
LanguageEnglish
Published 27.06.2008
Online AccessGet full text

Cover

More Information
Summary:USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA The present invention relates to the use of agomelatine, or N-[2-(7-methoxy- l-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of periventricular leukomalacia.
Bibliography:Application Number: SG20070180367